Tech Company Financing Transactions
10X Genomics Funding Round
10X Genomics closed a $75 million funding round on 4/27/2018. Investors included Silicon Valley Bank.
Transaction Overview
Company Name
Announced On
4/27/2018
Transaction Type
Debt
Amount
$75,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds from these financings will fuel the Company's innovation engine and will allow investment in new strategic opportunities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7068 Koll Center Pkwy. 401
Pleasanton, CA 94566
USA
Pleasanton, CA 94566
USA
Phone
Website
Email Address
Overview
A transformative upgrade to short-read sequencers that fits easily into existing lab infrastructure. DNA or Cellular Input For DNA applications, start with only 1 ng of DNA. For single-cell applications, start with thousands of cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Serge Saxonov
Chief Financial Officer
Justin McAnear
Chief Scientific Officer
Ben Hindson
Vice President
Alexander Wong
VP - Finance
Jamie Osborn
VP - General Counsel
Eric Whitaker
VP - Human Resources
Jean Philibert
VP - Operations
Jonathan Schimmel
VP - Operations
Paul Wyatt
VP - Product Management
Michael Schnall-Levin
VP - Sales
Sam Ropp
Browse more venture capital transactions:
Prev: 4/27/2018: NuMat Technologies venture capital transaction
Next: 4/27/2018: Onboard Dynamics venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs